BATS BZX Real-Time Price
As of 9:42am ET
| +0.06 / +1.03%|
The 4 analysts offering 12-month price forecasts for Regulus Therapeutics Inc have a median target of 27.50, with a high estimate of 42.00 and a low estimate of 15.00. The median estimate represents a +365.31% increase from the last price of 5.91.
The current consensus among 6 polled investment analysts is to Buy stock in Regulus Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.